Clinical Trial Update: A Study of MK0359 in Patients With Chronic Asthma (0359-013) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MK0359 in patients with chronic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK0359

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED